Antiva wants to help treat cervical cancer. Most male investors aren’t interested.

A young pharmaceutical startup wants to develop a groundbreaking new treatment for a relatively common cancer. Yet it struggles to find funding. That’s because the startup in question is Antiva Biosciences, and the cancer it aims to treat is cervical cancer. Stat reported Thursday on the company’s struggles to attract investment, as well as its […]

Continue reading


Antiva wants to help treat cervical cancer. Most male investors aren’t interested.

A young pharmaceutical startup wants to develop a groundbreaking new treatment for a relatively common cancer. Yet it struggles to find funding. That’s because the startup in question is Antiva Biosciences, and the cancer it aims to treat is cervical cancer. Stat reported Thursday on the company’s struggles to attract investment, as well as its […]

Continue reading


EpiPen Gets Its First Generic Rival After Criticism for High Price

(Bloomberg) — EpiPen, a life-saving allergy treatment widely criticized for its high price tag, will get generic competition for the first time since the autoinjector was approved more than two decades ago. The Food and Drug Administration on Thursday cleared Teva Pharmaceutical Industries Ltd.’s generic EpiPen and EpiPen Jr. for sale, several years after the […]

Continue reading